Where does Solco Biomedical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Solco Biomedical Co., Ltd. ranks #17,216 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Solco Biomedical Co., Ltd. hold?

Solco Biomedical Co., Ltd. holds 17 US utility patents granted between 2018 and 2022, spanning 6 technology areas.

What is Solco Biomedical Co., Ltd.'s Innovation Score?

Solco Biomedical Co., Ltd. has an Innovation Score of 27.3 out of 100 (23rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Solco Biomedical Co., Ltd. focus on?

Solco Biomedical Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Solco Biomedical Co., Ltd.'s patent grant rate increasing or decreasing?

Solco Biomedical Co., Ltd.'s recent grant velocity is +43% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Solco Biomedical Co., Ltd.'s patents?

Solco Biomedical Co., Ltd.'s patents average 4.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Solco Biomedical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Solco Biomedical Co., Ltd.

USPTO PatentsView assignee record - 17 granted patents across 6 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Solco ranks #17,216 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 6 technology areas.

#17,216
of 49,997 US assignees by volume: 23rd percentile
by Innovation Score (27.3/100): 4.7
avg claims per patent: +43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17216 · Foreign Corporation #17,216 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #17,216/49,997
PHOTO-FINISH Sipco
CPC-NARROW A61B · 6 areas
INNOV-THIN 27.3/100
CLAIMS-SPARSE 4.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sipco, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Solco’s 27.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (37%) Velocity 5.8 pts (21%) Breadth 8.7 pts (32%) Claim depth 2.8 pts (10%)

Qualcomm Incorporated · highest

85
Solco Biomedical · this assignee

27
3D Lighting… · lowest

7

What this shows Solco's Innovation Score is 27.3/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Solco?

Each dot is one of Solco’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Solco’s own 4.7 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Solco vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Solco's grants concentrate

Solco Biomedical Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 41.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (7 grants) versus a trough of 1 in 2020. By volume, Solco sits between Sipco, LLC and Spatial Systems Inc..

Solco's three-year grant acceleration

Solco Biomedical Co., Ltd. shows 7 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sipco

17
Soft Machines

17
Solar Junction

17
Solarlab Aiko Eur…

17
Sortera

17
Source

17
Spartus

17
Spatial Systems

17
Solco Biomedical ◀

17

What this shows Solco holds 17 patents at rank #17,181, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Solco

By rank, the assignees closest to #17,181 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Solco's primary technology class.

Solco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 23rd percentile higher than 23% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Solco Biomedical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	11.8%
2019	5	29.4%
2020	1	5.9%
2021	2	11.8%
2022	7	41.2%

Which technologies does Solco Biomedical Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

C25B - Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor 2

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 2

C02F - Treatment OF Water, Waste Water, Sewage, OR Sludge 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Solco Biomedical Co., Ltd.'s patent record in context - here's where to go next.

Solco Biomedical Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 41.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #17,216 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Solco Biomedical Co., Ltd. against Sipco, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.